AI/ML Innovations Appoints Erik Suokas as COO to Enhance Commercial Success

AI/ML Innovations Inc. has announced the appointment of Erik Suokas as Chief Operating Officer. This development aims to boost the company's leadership at a pivotal time as it moves from innovation to commercial scale. Suokas, with over 20 years of experience in healthcare and MedTech, will supervise daily operations, commercial strategy, and contract discipline.

The appointment signals AIML's commitment to disciplined execution and scalable delivery, aligning innovation with strategic expansion. Suokas’ track record includes significant revenue growth at Sun Nuclear North America. Paul Duffy, CEO, and Esmat Naikyar, Chief Product Officer, both highlight Suokas' ability to effectively translate innovations into customer outcomes.

Suokas will focus on fortifying AIML's operational systems, ensuring strong commercial agreements and aligning product commitments. AIML, trading under CSE:AIML, AIMLF, and 42FB, is advancing AI-driven solutions in cardiac health, poised for growth in clinical and enterprise markets.